Technical Analysis for ORGS - Orgenesis Inc.

Grade Last Price % Change Price Change
C 6.69 -2.90% -0.20
ORGS closed down 2.9 percent on Friday, February 26, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ORGS trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Calm After Storm Range Contraction -5.77%
20 DMA Support Bullish -4.43%
Pocket Pivot Bullish Swing Setup -4.43%
Spinning Top Other -4.43%
Calm After Storm Range Contraction -4.43%
Calm After Storm Range Contraction -2.34%
Outside Day Range Expansion -2.34%
Older End-of-Day Signals for ORGS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 2 days ago
20 DMA Support 2 days ago
Down 2 % 2 days ago
60 Minute Opening Range Breakdown 2 days ago
Down 1% 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Orgenesis Inc. Description

Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Clinical Development Diabetes Stem Cells Endocrine System Insulin Hormones Cell Therapy Regenerative Medicine Contract Manufacturing Contract Manufacturing Services Peptide Hormones I Diabetes Medicinal Product Assay Development Services Diabetes Mellitus Type 1 Manufacturing Practice Medicinal Products

Is ORGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.2
52 Week Low 2.76
Average Volume 164,696
200-Day Moving Average 5.66
50-Day Moving Average 5.88
20-Day Moving Average 6.88
10-Day Moving Average 6.92
Average True Range 0.49
ADX 47.95
+DI 27.30
-DI 16.54
Chandelier Exit (Long, 3 ATRs ) 6.51
Chandelier Exit (Short, 3 ATRs ) 7.49
Upper Bollinger Band 7.21
Lower Bollinger Band 6.54
Percent B (%b) 0.22
BandWidth 9.72
MACD Line 0.26
MACD Signal Line 0.34
MACD Histogram -0.0776
Fundamentals Value
Market Cap 161.6 Million
Num Shares 24.2 Million
EPS 2.35
Price-to-Earnings (P/E) Ratio 2.85
Price-to-Sales 6.64
Price-to-Book 1.38
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.25
Resistance 3 (R3) 7.29 7.16 7.15
Resistance 2 (R2) 7.16 7.02 7.13 7.12
Resistance 1 (R1) 6.92 6.93 6.86 6.88 7.09
Pivot Point 6.79 6.79 6.75 6.76 6.79
Support 1 (S1) 6.55 6.65 6.49 6.51 6.29
Support 2 (S2) 6.42 6.56 6.39 6.26
Support 3 (S3) 6.18 6.42 6.23
Support 4 (S4) 6.14